Annual EBITDA
-$210.70 M
-$769.20 M-137.73%
December 31, 2023
Summary
- As of February 7, 2025, AHCO annual EBITDA is -$210.70 million, with the most recent change of -$769.20 million (-137.73%) on December 31, 2023.
- During the last 3 years, AHCO annual EBITDA has fallen by -$128.54 million (-156.43%).
- AHCO annual EBITDA is now -137.73% below its all-time high of $558.49 million, reached on December 31, 2022.
Performance
AHCO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$154.22 M
+$2.24 M+1.47%
September 30, 2024
Summary
- As of February 7, 2025, AHCO quarterly EBITDA is $154.22 million, with the most recent change of +$2.24 million (+1.47%) on September 30, 2024.
- Over the past year, AHCO quarterly EBITDA has increased by +$512.10 million (+143.09%).
- AHCO quarterly EBITDA is now -14.00% below its all-time high of $179.33 million, reached on June 30, 2021.
Performance
AHCO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$291.21 M
+$512.10 M+231.83%
September 30, 2024
Summary
- As of February 7, 2025, AHCO TTM EBITDA is $291.21 million, with the most recent change of +$512.10 million (+231.83%) on September 30, 2024.
- Over the past year, AHCO TTM EBITDA has increased by +$220.06 million (+309.30%).
- AHCO TTM EBITDA is now -53.76% below its all-time high of $629.79 million, reached on March 31, 2022.
Performance
AHCO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AHCO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -137.7% | +143.1% | +309.3% |
| 3 y3 years | -156.4% | -6.3% | -16.4% |
| 5 y5 years | -10000.0% | +502.5% | +494.4% |
AHCO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -137.7% | at low | at high | +143.1% | -53.8% | +231.8% |
| 5 y | 5-year | -137.7% | at low | -14.0% | +143.1% | -53.8% | +231.8% |
| alltime | all time | -137.7% | at low | -14.0% | +143.1% | -53.8% | +231.8% |
AdaptHealth EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $154.22 M(+1.5%) | $291.21 M(-231.8%) |
| Jun 2024 | - | $151.98 M(+16.1%) | -$220.89 M(+0.1%) |
| Mar 2024 | - | $130.85 M(-189.7%) | -$220.58 M(+4.7%) |
| Dec 2023 | -$210.70 M(-137.7%) | -$145.84 M(-59.3%) | -$210.70 M(-396.1%) |
| Sep 2023 | - | -$357.88 M(-335.0%) | $71.15 M(-87.6%) |
| Jun 2023 | - | $152.29 M(+8.2%) | $572.69 M(+4.2%) |
| Mar 2023 | - | $140.73 M(+3.5%) | $549.58 M(-1.6%) |
| Dec 2022 | $558.49 M(+2.6%) | $136.01 M(-5.3%) | $558.49 M(-0.1%) |
| Sep 2022 | - | $143.66 M(+11.2%) | $558.81 M(-3.6%) |
| Jun 2022 | - | $129.18 M(-13.7%) | $579.65 M(-8.0%) |
| Mar 2022 | - | $149.64 M(+9.8%) | $629.79 M(+15.7%) |
| Dec 2021 | $544.21 M | $136.33 M(-17.1%) | $544.21 M(+56.2%) |
| Sep 2021 | - | $164.49 M(-8.3%) | $348.33 M(+129.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $179.33 M(+180.0%) | $152.09 M(+1731.6%) |
| Mar 2021 | - | $64.05 M(-207.6%) | $8.30 M(-110.1%) |
| Dec 2020 | -$82.17 M(-202.7%) | -$59.54 M(+87.6%) | -$82.17 M(+464.6%) |
| Sep 2020 | - | -$31.75 M(-189.3%) | -$14.55 M(-134.0%) |
| Jun 2020 | - | $35.54 M(-234.5%) | $42.79 M(+86.7%) |
| Mar 2020 | - | -$26.42 M(-427.3%) | $22.92 M(-53.2%) |
| Dec 2019 | $80.01 M(-6585.3%) | $8.07 M(-68.5%) | $48.99 M(+21.1%) |
| Sep 2019 | - | $25.59 M(+63.3%) | $40.44 M(+180.8%) |
| Jun 2019 | - | $15.67 M(-4689.6%) | $14.40 M(-1058.4%) |
| Mar 2019 | - | -$341.40 K(-29.2%) | -$1.50 M(+21.8%) |
| Dec 2018 | -$1.23 M | -$482.00 K(+8.4%) | -$1.23 M(+64.1%) |
| Sep 2018 | - | -$444.80 K(+89.8%) | -$751.70 K(+144.9%) |
| Jun 2018 | - | -$234.40 K(+223.3%) | -$306.90 K(+323.3%) |
| Mar 2018 | - | -$72.50 K | -$72.50 K |
FAQ
- What is AdaptHealth annual EBITDA?
- What is the all time high annual EBITDA for AdaptHealth?
- What is AdaptHealth annual EBITDA year-on-year change?
- What is AdaptHealth quarterly EBITDA?
- What is the all time high quarterly EBITDA for AdaptHealth?
- What is AdaptHealth quarterly EBITDA year-on-year change?
- What is AdaptHealth TTM EBITDA?
- What is the all time high TTM EBITDA for AdaptHealth?
- What is AdaptHealth TTM EBITDA year-on-year change?
What is AdaptHealth annual EBITDA?
The current annual EBITDA of AHCO is -$210.70 M
What is the all time high annual EBITDA for AdaptHealth?
AdaptHealth all-time high annual EBITDA is $558.49 M
What is AdaptHealth annual EBITDA year-on-year change?
Over the past year, AHCO annual EBITDA has changed by -$769.20 M (-137.73%)
What is AdaptHealth quarterly EBITDA?
The current quarterly EBITDA of AHCO is $154.22 M
What is the all time high quarterly EBITDA for AdaptHealth?
AdaptHealth all-time high quarterly EBITDA is $179.33 M
What is AdaptHealth quarterly EBITDA year-on-year change?
Over the past year, AHCO quarterly EBITDA has changed by +$512.10 M (+143.09%)
What is AdaptHealth TTM EBITDA?
The current TTM EBITDA of AHCO is $291.21 M
What is the all time high TTM EBITDA for AdaptHealth?
AdaptHealth all-time high TTM EBITDA is $629.79 M
What is AdaptHealth TTM EBITDA year-on-year change?
Over the past year, AHCO TTM EBITDA has changed by +$220.06 M (+309.30%)